TORONTO, December 26, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Pursue” or “acerus“) ASPASPCF announced today that Mr. Scott Leckie has resigned from the Company’s Board of Directors, effective immediately.
About Acerus
Acerus Pharmaceuticals Corporation is a specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve the patient experience, with a primary focus in the area of men’s health.
Acerus shares trade on the TSX under the symbol ASP and on the OTCQB under the symbol ASPCF. For more information visit www.aceruspharma.com and keep following us Twitter and LinkedIn.
company contact
Naved Manzoor
CFO
ir@aceruspharma.com
© 2022 Benzinga.de. Benzinga does not provide investment advice. All rights reserved.
[ad_2]
Source story
